Literature DB >> 25123949

Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples.

L Capelli1, C Marfisi2, M Puccetti3, L Saragoni4, F De Paola4, A Zaccaroni2, E Chiadini1, L Gagliardi5, G Ferretti1, W Zoli1, P Ulivi1.   

Abstract

BACKGROUND: Although fine needle aspiration (FNA) is the standard diagnostic test for the characterization of a suspicious thyroid nodule, in some cases cytological evaluation is inconclusive. The aim of this study was to determine the role of BRAF mutation in aiding diagnosis and to verify whether archival cytological samples could be suitable for molecular analysis.
METHODS: Eighty-five patients with suspicious (Thy4) or follicular (Thy3) lesions on cytology were resubmitted to a second FNA for BRAF mutation analysis. Of these, 56 subsequently underwent surgery. The usefulness of archival samples for molecular analysis was also studied in a second cohort of 42 patients with a confirmed diagnosis of papillary thyroid carcinoma for whom both archived paraffin-embedded histological samples and cytological smears were available. A further 15 patients with paired fresh FNA and archived cytological and histological samples were recruited.
RESULTS: BRAF mutation was found in the fresh FNA samples from 10 of 56 patients who had surgery with previous inconclusive cytology (4/45, 9%, Thy3 and 6/11, 55%, Thy4). The BRAF test showed a specificity and positive predictive value of 100% (26/26 and 10/10, respectively), sensitivity of 33% (10/30) and negative predictive value of 57% (26/46). There was absolute concordance between the BRAF results obtained with 42 histological and cytological archived samples. BRAF analysis on 15 archived cytological samples showed absolute concordance with histology, whereas there was one false negative on the matched fresh FNA.
CONCLUSION: BRAF analysis is a highly specific test that can facilitate cytological diagnosis in some cases and can also be performed on archived cytological samples.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  BRAF; cytological samples; fine needle aspiration; mutation; papillary thyroid carcinoma; thyroid nodules

Mesh:

Substances:

Year:  2014        PMID: 25123949     DOI: 10.1111/cyt.12199

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  4 in total

Review 1.  Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.

Authors:  Pierpaolo Trimboli; Lorenzo Scappaticcio; Giorgio Treglia; Leo Guidobaldi; Massimo Bongiovanni; Luca Giovanella
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

Review 2.  The Role and Importance of Molecular Tests in Approach to Thyroid Nodules.

Authors:  Levent Gürbüzler
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-04-06

3.  BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland.

Authors:  Sohail Bakkar; Elisabetta Macerola; Qusai Aljarrah; Agnese Proietti; Gabriele Materazzi; Fulvio Basolo; Paolo Miccoli
Journal:  Updates Surg       Date:  2019-10-04

4.  The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC.

Authors:  Vivian Y Park; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Jin Young Kwak
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.